Lantheus reports mixed Q3 results

By staff writers

November 5, 2020 -- Lantheus Holdings, parent company of Lantheus Medical Imaging, has released mixed results for its third quarter.

The company posted $88.5 million in worldwide revenue, a 3.2% increase over $85.8 million during the same period last year. It attributed this increase to sales of its Definity ultrasound contrast agent.

However, the firm also posted a net loss of $6.4 million for the quarter (end-September 30), compared with net income of $4.9 million in 2019.

In April, Lantheus Holdings withdrew its 2020 revenue, revenue growth, and earnings guidance due to the COVID-19 pandemic.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking